Weight Loss

Everyone Knows the Names. But Do You Understand How They Actually Work?

Peptide NavigatorJuly 12, 20269 min read
Share

Everyone knows Ozempic, Wegovy, Mounjaro, Zepbound. But do you actually understand how they work and what they're made of? Most people don't. You're trying to figure out if one of these is right for you, what the real benefits are, the side effects, how to use it, injection versus pill. We're gonna tell you the truth about all of them, so you're better informed. When you talk to your doctor or make a decision, you'll know what you're actually dealing with.

A family of different ages looking confused while researching Ozempic, Wegovy and other GLP-1 weight loss drugs on phones, a tablet and a laptop
Everyone knows the names. Almost nobody explains what they actually are. This guide does.

And before we go any further: congratulate yourself. Wanting to understand something before you put it in your body is the smartest first move you can make. Most people never get past the ad. You already have.

A brand is just a brand

Here is the part nobody explains up front. Ozempic and Wegovy are not two different medicines. They are the same drug, semaglutide, sold under two names for two purposes. Mounjaro and Zepbound are also the same drug as each other, tirzepatide, wearing two labels. The brand on the box is marketing. The molecule inside is the medicine.

Think of it like a burger. A Quarter Pounder with Cheese in the United States is a Royale with Cheese in France. Different name, same thing on the grill. Ozempic, Wegovy, Rybelsus: all semaglutide. Mounjaro, Zepbound: all tirzepatide. Once you see that, the whole conversation gets simpler, and a lot harder to sell to.

The brands you know
Ozempic Wegovy Rybelsus
Mounjaro Zepbound
The actual medicine
Semaglutide
Tirzepatide
Ten names on the shelf. Two medicines in the vial. The brand is marketing; the molecule is the medicine.

So when you hear ten different names thrown around, you are really only looking at a small handful of actual medicines:

  • Semaglutide (sold as Ozempic, Wegovy, and the oral pill Rybelsus)
  • Tirzepatide (sold as Mounjaro and Zepbound)
  • Retatrutide (no brand name yet, still in trials, and the strongest of the group so far)
  • Orforglipron (a newer daily pill sold as Foundayo, and it works a little differently, more on that below)

Learn those, and you have cut through 90 percent of the noise.

Follow the money, because they are

You cannot understand the hype until you understand the size of the prize. This is one of the biggest money stories in the history of medicine.

The five biggest of these drugs, Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound, have already pulled in tens of billions of dollars in the United States alone since they launched, and analysts project the class will bring in hundreds of billions more by 2030. Eli Lilly is on track to become the top selling drug company on the planet on the back of these medicines. That is not a knock. It is context. When there is that much money on the table, you are not the customer anymore. You are the market. And a market gets marketed to, not leveled with.

Here is a clean example of what that looks like in practice. During the shortage a few years back, when people were paying around 1,300 dollars a month out of pocket, the story you heard was "we can't make enough." That was only half true. The active drug itself was never the bottleneck. The bottleneck was the pre filled injector pen, the little plastic auto injector device. The medicine inside was available. Compounding pharmacies proved it by supplying the same drug in a plain vial with a syringe, which is far simpler and cheaper to produce than a fancy pen. So when you were told the medicine was scarce, what was actually scarce was the premium delivery device the manufacturers had built their pricing around. Read that again. The shortage people lived through was largely a packaging problem dressed up as a supply crisis.

We are not telling you this to make you angry. We are telling you so you stop taking the marketing at face value. These companies make real medicine that helps real people. They also protect their margins ruthlessly, and they will let you assume things that are good for the stock price. Knowing that is part of being informed.

What these drugs actually do to your body

Now the science, in plain English, no lab coat required.

Your gut naturally makes a hormone after you eat. That hormone does three simple things: it tells your pancreas to help manage your blood sugar, it slows down how fast your stomach empties, and it sends a signal to your brain that says "you're full, you can stop now." In a lot of people carrying extra weight, that signal is weak or gets drowned out. You eat, and your brain never quite gets the message.

These drugs are copies of that hormone, turned up loud. They keep the "I'm full" signal switched on far longer than your body does on its own. Your stomach stays fuller for longer. Your appetite quiets down. The constant background noise of food cravings, the thing willpower alone rarely beats, gets turned way down. That is the whole trick. They do not melt fat. They change your relationship with hunger so that eating less stops feeling like a fight.

That is also why the newer ones are stronger. Semaglutide hits one of these hunger signals. Tirzepatide hits two at once. Retatrutide, the one still in trials, hits three. More signals, more effect. That is the entire logic of the arms race, and now you understand it better than most of the people prescribing it.

The differences that actually matter

They are not all the same strength, and this is where honest numbers matter.

In the first head to head trial that put them in the ring together, tirzepatide (Mounjaro, Zepbound) produced greater average weight loss than semaglutide (Ozempic, Wegovy) over about 17 months. Roughly one in three people on tirzepatide lost at least a quarter of their body weight, compared to about one in six on semaglutide. Both are effective. One is simply stronger on average.

Retatrutide, the triple signal drug, has shown the largest weight loss numbers recorded in this class so far in its trials, in the range of a quarter to nearly a third of body weight at the highest doses. It is not approved yet. Its trial program is still running, with a decision from the FDA not expected until 2027 or later. So if a website or a seller is offering you retatrutide today, understand that it has not cleared the finish line, and anything sold outside a clinical trial is outside the system that exists to keep you safe.

One more honest note, because we do not hide the bad parts: the stronger the drug, the more the body tends to react. Retatrutide's trials flagged a new side effect, a skin tingling and sensitivity, in a meaningful share of people on the top dose. Bigger effect, bigger footprint. That is the trade, and your doctor is the person to weigh it with you.

Injection versus pill: this is the question people actually ask

A lot of people land here for one reason. They do not want to stick themselves with a needle. Fair. So let's be straight about it.

For years, all of these were injections, a small shot under the skin, usually once a week. The reason was not stubbornness. Semaglutide and tirzepatide are peptides, which are delicate chains of amino acids. Swallow a peptide and your stomach acid tears it apart before it can work. So they had to be injected to survive the trip.

Then two things changed the game:

The semaglutide pill. There is now an oral version of semaglutide approved for weight loss. It works, but it is fussy. Because it is still that fragile peptide, you have to take it on an empty stomach in the morning, with only a small sip of water, and then wait before eating or drinking anything else. Miss those rules and your body does not absorb it well. It trades the needle for a strict routine.

The non peptide pill. The bigger shift is a newer daily pill, orforglipron, sold as Foundayo. This one is not a peptide at all. It is a small, sturdy molecule built to survive your gut, so you can take it any time of day, with food or without, no fasting ritual. In its trials it produced solid weight loss, a bit less on average than the strongest injections, but no needle and no routine to babysit.

So the real trade off is this. Injections are generally the strongest option and the most established. The pills are more convenient, and for a lot of people that convenience is the difference between actually sticking with it and quitting in month two. Different results, different lifestyles, different right answers for different people. There is no single best. There is a best for you, and that is a conversation for a doctor, not a checkout page.

Weekly injectionSemaglutide, tirzepatide
Semaglutide pillOral Wegovy
Non-peptide pillOrforglipron (Foundayo)
Strength
Strongest on average
Effective
Solid, slightly less
Convenience
A weekly needle
Pill, strict routine
Pill, any time
Daily routine
Once a week
Empty stomach, morning, then wait
With or without food, any time
A simplified comparison. Strength and side effects vary by person and dose. Which is right for you is a decision for your doctor, not a checkout page.

The side effects, told straight

The most common issues are stomach related: nausea, constipation or diarrhea, sometimes vomiting, especially in the early weeks as your body adjusts. For most people these ease up over time. This is exactly why every one of these drugs is started low and increased slowly under a prescriber's care. That slow ramp is not a formality. It is the thing that keeps the side effects tolerable, and it is one of many reasons this is not a do it yourself project.

There are more serious considerations too, involving your pancreas, your gallbladder, thyroid history, and how these interact with other conditions and medications. We are not going to pretend a web article can screen you for those. That is the entire job of the licensed professional who writes the prescription and knows your history. The point here is simple: real medicine, real benefits, real risks, all of which deserve a real evaluation.

The part the ad will never tell you

Here is the truth that does not fit on a billboard. These drugs are not a magic wand, and anyone who lets you believe otherwise is selling you something.

They are a powerful assist. They quiet the hunger so the hard part gets easier. But they work with your effort, not instead of it. The people who get the best, most lasting results are the ones who use the quiet the drug gives them to actually build the basics: eating real food, moving their body, lifting a little, sleeping enough, and doing it week after week. It is a slow process. It is measured in months, not days. Stop the medicine without having built any of those habits, and the appetite tends to come roaring back, and the weight often follows.

The pharmaceutical company is not going to walk you through any of that. They will sell you the shot and move on to the next customer. That is not their job. It is ours. We are giving you the whole picture, the science and the work, because that is the only version of this that actually helps you succeed.

And that is exactly why we made the full guide free. We are taking the opposite approach to big pharma. They gatekeep and upsell. We are just going to hand you the information, the whole thing, no paywall, because we believe an informed person makes a better decision. If it helps you, come back. We will be here for the next step.

How you actually get it, the right way

Straight answer: every one of these is a prescription medicine. The legitimate path is a licensed healthcare provider who evaluates you, and a real, licensed pharmacy that fills it. That is it. That is the whole map.

Be careful out there. Where there is this much demand and this much money, the counterfeit and grey market crowd shows up fast, selling "research" vials and unverified powders with no oversight and no idea what is actually in the bottle. Regulators have been blunt about the risks. The savings are not worth gambling with something you inject into your body. If a deal skips the doctor and skips the pharmacy, that is not a shortcut. That is the risk.

Your decision, made with real information

Whether to try one of these is your decision, and yours alone. Nobody, not a company, not an influencer, not us, should make it for you. Our job is to make sure that when you walk into your doctor's office, you walk in understanding the medicine, the trade offs, and the questions worth asking. That is what informed looks like. That is the whole point of this page.

If you have gotten this far, you are already doing the thing most people skip. And once you are on a path that is working, there is a wider world of peptides showing real promise for recovery, tissue repair, and healthy aging that can support the results you are building. We cover those the same way we covered this: honestly, with the evidence, and always pointing you back to a professional for the how.

Bookmark this. Talk to your doctor. And keep asking exactly the kind of question that brought you here.

Read more and follow along

Explore the full library of evidence-first peptide guides, free articles, and tools at peptidenav.com. For the latest peptide research, FDA developments, and honest breakdowns:

Sources and further reading

Every claim above is grounded in the primary research and regulatory record. Aronne LJ, et al. Tirzepatide vs Semaglutide for the Treatment of Obesity (SURMOUNT-5 head-to-head trial), New England Journal of Medicine, 2025. Jastreboff AM, et al. Triple Hormone Receptor Agonist Retatrutide for Obesity, a Phase 2 Trial, NEJM 2023. Eli Lilly TRIUMPH Phase 3 program for retatrutide, 2025 to 2026. FDA approval of oral semaglutide (Wegovy pill), December 2025. FDA approval of orforglipron (Foundayo), April 1, 2026. ATTAIN-1 Phase 3 orforglipron obesity trial, 2026. FDA, Resolution of Semaglutide Injection Product Shortage, February 2025. Market projections for the GLP-1 class through 2030, as reported 2025 to 2026.

This article summarizes publicly reported information as of July 2026 and is educational, not medical or legal advice. Regulatory status and evidence can change. Always consult a licensed healthcare professional.